Triple Green Farms CBD Gummies Review 2026: What to Know

Disclosure: This article may contain affiliate links. If you click a link and make a purchase, we may receive a commission at no additional cost to you. All opinions remain our own.

Disclaimer: This article is for educational and informational purposes only. It is not medical advice and does not constitute guidance from Kidney Disease and Hypertension Centers, PA or its physicians. These statements have not been evaluated by the Food and Drug Administration. Triple Green Farms CBD Gummies is not intended to diagnose, treat, cure, or prevent any disease. Individuals with kidney disease, chronic health conditions, or those taking prescription medications — particularly immunosuppressants — must consult their nephrologist or healthcare provider before using any hemp-derived supplement. State and federal legal status of hemp-derived cannabinoid products is subject to change. Individual results vary. KidneyDiseaseMS.com is an independent health research publication, not a medical practice.

By KidneyDiseaseMS.com Editorial Team

Quick Answer: Triple Green Farms CBD Gummies is a hemp-derived, full-spectrum CBD supplement manufactured in the USA and sold direct-to-consumer in 500MG and 1000MG bottle options. Pricing starts at $119.00 for two bottles under the Subscribe and Save plan, which also includes a $19.93/month recurring digital publication charge not disclosed in the main marketing copy. The refund window is 30 days, requires a phone call for an RMA number, and product must arrive at the fulfillment center within that window. Kidney transplant patients face a specific, verified drug interaction risk: CBD inhibits CYP3A4, the enzyme that metabolizes tacrolimus and cyclosporine. Consult your transplant team before use. The brand also uses full-spectrum and THC-free language inconsistently across its properties.

The ads have been everywhere. A gummy supplement described as natural, powerful, non-habit-forming, made in the USA, and capable of addressing pain, sleep, stress, and focus simultaneously. For anyone managing a chronic condition like kidney disease, the reflexive question should be a different one: what exactly is in this product, what are the actual terms, and does anyone on my medication list have a reason to be careful?

This review answers those questions from verified sources — the brand's own Terms and Conditions, peer-reviewed drug interaction literature, and the current federal regulatory record. Nothing in this article is borrowed from the marketing copy without independent verification. Where the brand's claims could not be verified, they are flagged as such.

What Is Triple Green Farms CBD Gummies?

Triple Green Farms CBD Gummies is a direct-to-consumer dietary supplement produced by Triple Green Farms Gummies and sold through its official ordering website. According to the brand's published materials, the product is a hemp-derived full-spectrum CBD gummy supplement available in 500MG and 1000MG potency options per bottle.

The brand describes the formulation as using cold-pressed, unrefined CBD oil processed through CO2 extraction with a triple filtration step for lead removal. The product is positioned as containing a full-spectrum cannabinoid profile rather than CBD isolate — meaning it is designed to retain the naturally occurring cannabinoids, terpenes, and flavonoids found in hemp, including trace THC within the federally permitted threshold under the 2018 Farm Bill's prior definition.

One disclosure issue worth flagging at the outset: at least one brand-affiliated website describes the product as THC-free, while the primary ordering site and brand materials consistently describe it as full-spectrum. Full-spectrum and THC-free are mutually exclusive by definition. CBD isolate is THC-free; full-spectrum products retain trace THC. This discrepancy is unresolved in the brand's public-facing materials and is documented further in the What We Verified section below.

Who This Is For

Triple Green Farms CBD Gummies is positioned as a general wellness supplement for adults seeking convenience and ease of use in a CBD delivery format. Gummies offer consistent, pre-measured dosing compared to tinctures, which require measuring and may have a taste that discourages daily compliance. The brand markets the product toward adults experiencing daily stress, occasional sleep difficulties, general physical discomfort, and those seeking a non-pharmaceutical support option.

For readers of this site considering a CBD gummy supplement as a complementary wellness option — and who do not have active kidney disease, are not taking immunosuppressant medications, and have discussed supplement use with their physician — the general considerations for CBD gummies as a category apply. Those considerations are covered in detail in our category review: how the endocannabinoid system relates to kidney health.

Who This Is NOT For

Kidney transplant patients on tacrolimus or cyclosporine should not take any CBD product without explicit guidance from their transplant nephrologist and pharmacist. This is not precautionary language. Cannabidiol inhibits cytochrome P450 enzymes CYP3A4 and CYP2C19 — the same pathways that metabolize calcineurin inhibitors. Published clinical case reports have documented approximately a three-fold increase in tacrolimus blood concentrations in a patient receiving concurrent CBD. A separate case report documented an interaction between CBD, cyclosporine, and mycophenolate mofetil in a kidney transplant patient with ESKD. Elevated immunosuppressant concentrations can cause drug toxicity. Insufficient concentrations risk organ rejection. The interaction mechanism is pharmacological, not brand-specific. It applies regardless of what CBD product is used. See our full guide: CBD drug interactions and kidney disease safety.

This product is also not appropriate for individuals under 21. It should not be used during pregnancy or while nursing without physician guidance. Patients with liver disease should be aware that CBD at higher doses has been associated with liver enzyme elevations in published studies. Anyone currently taking anticoagulants, antiepileptic medications, or other drugs with narrow therapeutic windows should review drug interactions with a pharmacist before starting any CBD supplement.

How Triple Green Farms CBD Gummies Works

CBD, or cannabidiol, interacts with the body's endocannabinoid system — a regulatory network of receptors distributed throughout the brain, nervous system, organs, and immune tissue. The two primary receptor types are CB1 and CB2. CBD is not a direct agonist at these receptors the way THC is. Instead, CBD appears to modulate endocannabinoid signaling indirectly and also interacts with non-cannabinoid receptors including serotonin 5-HT1A receptors and TRPV1 receptors involved in pain and inflammation signaling.

When CBD is ingested in gummy form, it passes through the digestive system before entering the bloodstream. This route of administration means onset takes longer than sublingual tinctures — typically 30 to 90 minutes depending on individual metabolism and whether the gummy is taken with food — but effects may last longer once they begin. The brand's recommendation of taking gummies after a meal aligns with evidence that CBD absorption improves with food, particularly fat-containing meals, due to its lipophilic nature.

The specific per-gummy CBD content for Triple Green Farms products is not disclosed on the brand's publicly accessible pages. The 500MG and 1000MG figures refer to the total CBD content per bottle, not per serving. Without knowing the number of gummies per bottle and per-serving dosage, it is not possible to verify per-dose potency from available materials. For a broader breakdown of how to evaluate any CBD product's label, including what full-spectrum means and how to interpret potency claims, see our research overview: CBD supplement research 2026.

What We Verified

The following was independently reviewed by the KidneyDiseaseMS.com Editorial Team on May 19, 2026, using the brand's published Terms and Conditions, product order pages, and verified federal regulatory sources.

Pricing — verified from published Terms and Conditions: Subscribe and Save: Buy 1 Get 1 Free at $119.00 plus $9.95 shipping and handling (two 500MG bottles); Buy 2 Get 1 Free at $159.00 with free shipping (three bottles); Buy 3 Get 2 Free at $199.00 with free shipping (five bottles). The 1000MG upgrade adds $9.99 per bottle to any tier. One-Time Purchase pricing is higher: $133.00, $180.00, and $234.00 for the same three package tiers respectively. Grab and Go options: 1000MG oil at $17.49 and 1000MG cream at $8.99.

Hidden subscription charge — confirmed: The Subscribe and Save option includes a $19.93 per month recurring charge for a Health and Wellness Digital Publication. This charge is disclosed in the Terms and Conditions but not in the main product marketing copy. Cancellation requires calling 888-582-5130, a separate number from the product customer service line. Customers intending a one-time purchase should select the One-Time Purchase option explicitly.

Refund policy — confirmed from Terms and Conditions: 30-day money-back guarantee. Process requires calling 833-201-0171 (8AM-9PM EST, Monday through Sunday) to receive a Return Merchandise Authorization number. The product must arrive at the fulfillment center within 30 days of the original purchase date. The buyer pays return shipping. Shipping and handling fees are not refunded. The company limits customers to one refund per product.

Contact — confirmed: General customer service: 833-201-0171. Digital publication cancellation: 888-582-5130. Credit card descriptor: Triple Green Farms Gummies 844-203-9923.

Supplement Facts panel — not accessible: Per-gummy CBD content is not disclosed on the brand's publicly available pages. Per-bottle totals (500MG, 1000MG) are stated, but per-serving dosage requires direct confirmation from the brand.

Full-spectrum vs. THC-free discrepancy — confirmed unresolved: The brand's primary ordering site and Terms describe the product as full-spectrum. At least one affiliated brand domain uses THC-free language. The brand has not publicly resolved this discrepancy. Readers requiring a verified THC-free formulation should confirm in writing with the company before purchasing.

Regulatory status — November 2026 change effective: P.L. 119-37, enacted November 12, 2025, modifies the federal definition of hemp to apply a total THC standard effective November 12, 2026. Full-spectrum CBD products whose total THC exceeds the new threshold may be reclassified as controlled substances at that date. Regulatory picture is still evolving. Verify compliance status with the brand before purchases made after September 2026.

Pricing and Policies in Detail

Triple Green Farms uses a multi-bottle incentive structure that makes single-bottle pricing opaque. Under the Subscribe and Save plan, the Buy 3 Get 2 Free option at $199.00 works out to approximately $39.80 per bottle for five bottles of the 500MG product. The comparable One-Time Purchase tier is $234.00 for five bottles, or approximately $46.80 per bottle. The Subscribe and Save discount comes bundled with the $19.93 per month digital publication, so the true monthly cost under subscription is higher than the product-only price suggests.

The Grab and Go options — 1000MG CBD oil at $17.49 and 1000MG cream at $8.99 — are listed in the Terms as separate products available at checkout. These are notably lower price points than the gummy bundles, though the product format and formulation differ. For readers comparing this pricing to other CBD gummy products, our comparison guide covers pricing alongside transparency and formulation characteristics: CBD gummies compared 2026.

Marketing Claims vs. What Can Be Verified

Triple Green Farms' marketing copy includes several claims that warrant context for the readers of this site. The brand's website references over 20,000 clinical studies as evidence for CBD's efficacy and uses language like “proven over and over again” and “medically proven to positively regulate your ECS.” These framings are not consistent with how clinical research is described in peer-reviewed literature. There is a growing body of ingredient-level research on cannabidiol — including systematic reviews — but the standard in that literature is “may support” and “warrants further study,” not “proven.”

The relevant regulatory standard is clear: these statements have not been evaluated by the Food and Drug Administration. The product is not intended to diagnose, treat, cure, or prevent any disease. Structure and function claims — that CBD may support relaxation or may support occasional sleep — are permissible under DSHEA. Claims of proof, cure, or guaranteed outcomes are not. What the research on CBD as a compound does support at appropriate dose ranges is reviewed in our ingredient research overview: CBD supplement research 2026.

Frequently Asked Questions

Is Triple Green Farms CBD Gummies full-spectrum or THC-free? The brand's primary ordering site describes it as full-spectrum. At least one brand-affiliated site uses THC-free language. These are mutually exclusive formulation categories. Verify directly with the company at 833-201-0171 before purchasing if this distinction matters for your situation.

Does Triple Green Farms have a hidden subscription? Yes. The Subscribe and Save option adds a $19.93 per month charge for a Health and Wellness Digital Publication. It is disclosed in the Terms and Conditions but not in the main marketing copy. Cancel at 888-582-5130. Select One-Time Purchase to avoid this charge.

What is the refund policy? 30-day guarantee, phone-only RMA required (833-201-0171), product must arrive at fulfillment center within 30 days of purchase. Return shipping is the buyer's cost. Shipping and handling is non-refundable.

Can kidney transplant patients use CBD gummies? This requires direct discussion with your transplant nephrologist and pharmacist. CBD inhibits CYP3A4, the enzyme metabolizing tacrolimus and cyclosporine. Published clinical reports document significant drug level changes with concurrent CBD use. Full interaction data is in our safety guide: CBD drug interactions and kidney disease.

Is CBD legal in 2026? Currently yes under existing law, but the federal definition of hemp is changing November 12, 2026 under P.L. 119-37. Full-spectrum products may be affected. Verify current status before purchasing after mid-2026.

Where is the Supplement Facts panel? Per-gummy CBD content is not disclosed in publicly available materials. Contact the brand directly for complete Supplement Facts panel information before purchasing.